IUCrData
(Sep 2017)
5-(7-Methanesulfonyl-2-morpholin-4-yl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-pyrimidin-2-ylamine mesylate
Masahide Aoki,
Takahiro Ichige,
Junichi Shiina,
Satoshi Tanida,
Koji Shiraki,
Masaki Ishigai
Affiliations
Masahide Aoki
Research Division, Chugai Pharmaceutical Co. Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan
Takahiro Ichige
Pharmaceutical Technology Division, Chugai Pharmaceutical Co. Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan
Junichi Shiina
Research Division, Chugai Pharmaceutical Co. Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan
Satoshi Tanida
Research Division, Chugai Pharmaceutical Co. Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan
Koji Shiraki
Research Division, Chugai Pharmaceutical Co. Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan
Masaki Ishigai
Research Division, Chugai Pharmaceutical Co. Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan
DOI
https://doi.org/10.1107/S2414314617012925
Journal volume & issue
Vol. 2,
no. 9
p.
x171292
Abstract
Read online
In the title compound, C15H20N7O3S+·CH3O3S− (CH5132799 mesylate), two molecular entities form a salt with proton transfer from methanesulfonic acid to the aminopyrimidine moiety of CH5132799. In the crystal, methanesulfonate is retained by bifurcated O...H—N hydrogen bonds and an N+—H...O− charge-assisted hydrogen bond.
Keywords
Published in IUCrData
ISSN
2414-3146 (Online)
Publisher
International Union of Crystallography
Country of publisher
United Kingdom
LCC subjects
Science: Chemistry: Crystallography
Website
https://iucrdata.iucr.org
About the journal
WeChat QR code
Close